DXCM
DexCom IncNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$29.08B
P/E Ratio
32.35
EPS
$2.33
Beta
1.44
52W High
$89.98
52W Low
$54.11
50-Day MA
$65.61
200-Day MA
$67.57
Dividend Yield
—
Profit Margin
19.30%
Forward P/E
29.41
PEG Ratio
1.40
About DexCom Inc
DexCom, Inc. is a company that develops, manufactures, and distributes continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with headquarters in San Diego, California, and has a manufacturing facility in Mesa, Arizona.
Fundamentals
| Revenue (TTM) | $4.82B |
| Gross Profit (TTM) | $2.96B |
| EBITDA | $1.29B |
| Operating Margin | 21.40% |
| Return on Equity | 35.60% |
| Return on Assets | 9.65% |
| Revenue/Share (TTM) | $12.39 |
| Book Value | $7.66 |
| Price-to-Book | 9.82 |
| Price-to-Sales (TTM) | 6.04 |
| EV/Revenue | 5.81 |
| EV/EBITDA | 18.93 |
| Quarterly Earnings Growth (YoY) | 92.20% |
| Quarterly Revenue Growth (YoY) | 15.00% |
| Shares Outstanding | $385.87M |
| Float | $384.51M |
| % Insiders | 0.28% |
| % Institutions | 102.69% |
Historical Volatility
HV 10-Day
39.75%
HV 20-Day
46.23%
HV 30-Day
44.62%
HV 60-Day
40.97%
HV Rank
70.2%
Volatility is currently contracting
Analyst Ratings
Consensus ($84.67 target)
3
Strong Buy21
Buy3
HoldMore HEALTHCARE Stocks
Data last updated: 6/13/2026